Trial Profile
Phase 2 clinical trial of galidesivir in non-hospitalized COVID-19 patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2020
Price :
$35
*
At a glance
- Drugs Galidesivir (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Sponsors BioCryst Pharmaceuticals
- 03 Sep 2020 New trial record